Anranfei (Kunshan) New Drug Development

BiotechnologyAngelSuzhou, China

Latest round

Angel

Last raised

Apr 2025

Total raised

Undisclosed

Investors

1

About Anranfei (Kunshan) New Drug Development

Based in Kunshan, China, and founded in 2023, Anranfei (Kunshan) New Drug Development is a biotechnology company engaged in human genetic diagnosis and treatment technology. The company is committed to the development of human genetic diagnosis and treatment technology, medical research and experimental development, health consulting services, etc.

Who invested in Anranfei (Kunshan) New Drug Development

1 investor across 1 round

See all investors in Anranfei (Kunshan) New Drug Development

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Apr 17, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Anranfei (Kunshan) New Drug Development

Who invested in Anranfei (Kunshan) New Drug Development?

Anranfei (Kunshan) New Drug Development has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Anranfei (Kunshan) New Drug Development raised?

Anranfei (Kunshan) New Drug Development has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Anranfei (Kunshan) New Drug Development last raise money?

Anranfei (Kunshan) New Drug Development's most recent round on record is a Angel, in Apr 2025.

What does Anranfei (Kunshan) New Drug Development do?

Based in Kunshan, China, and founded in 2023, Anranfei (Kunshan) New Drug Development is a biotechnology company engaged in human genetic diagnosis and treatment technology.

Where is Anranfei (Kunshan) New Drug Development headquartered?

Anranfei (Kunshan) New Drug Development is headquartered in Suzhou, China.

Which VCs invest in companies like Anranfei (Kunshan) New Drug Development?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Anranfei (Kunshan) New Drug Development's stage. Their profiles are linked below.

Raising like Anranfei (Kunshan) New Drug Development? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.